Multicenter evaluation of the reproducibility of the proposed antifungal susceptibility testing method for fermentative yeasts of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST) - PubMed (original) (raw)
doi: 10.1046/j.1469-0691.2003.00592.x.
C B Moore, F Barchiesi, J Bille, E Chryssanthou, D W Denning, J P Donnelly, F Dromer, B Dupont, J H Rex, M D Richardson, B Sancak, P E Verweij, J L Rodríguez-Tudela; AFST Subcommittee of the European Committee on Antimicrobial Susceptibility Testing
Affiliations
- PMID: 12848721
- DOI: 10.1046/j.1469-0691.2003.00592.x
Free article
Multicenter evaluation of the reproducibility of the proposed antifungal susceptibility testing method for fermentative yeasts of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST)
M Cuenca-Estrella et al. Clin Microbiol Infect. 2003 Jun.
Free article
Abstract
Objective: To evaluate the intra- and inter-laboratory reproducibility of a new standard for susceptibility testing of fermentative yeasts. This standard is based on the M27-A procedure of the National Committee for Clinical Laboratory Standards (NCCLS), but incorporates several modifications, including spectrophotometric growth-dependent endpoint reading.
Methods: Nine laboratories participated in the study. Common material lots were used to test six Candida species (one each of C. albicans, C. tropicalis, C. parapsilosis, C. glabrata, C. krusei, and C. lusitaniae), and two quality control strains (C. krusei ATCC6258 and C. parapsilosis ATCC22019). Triplicate testing on three separate days was performed in microtiter format with RPMI-2% glucose, pH 7.0. Flucytosine, fluconazole and itraconazole were tested. In total, 3888 MIC values were included in the analyses. Reproducibility was calculated by means of agreement (percentage of MICs within one two-fold dilution of the mode) and intraclass correlation coefficient (ICC, maximum value of 1).
Results: The average intra-laboratory agreements were 99% and 96% after 24 h and 48 h of incubation, respectively, with ICCs of 0.98 and 0.97 (P < 0.05). Two strains exhibiting a trailing effect showed intra-laboratory agreement of 92% and ICCs of < 0.91 at 48 h. The inter-laboratory agreement was 94% and 88% after 24 h and 48 h, respectively, with ICCs of 0.93 and 0.91 (P < 0.05). Lower values of agreement and ICCs were obtained for strains exhibiting trailing after 48 h of incubation. Itraconazole yielded the lowest values of reproducibility.
Conclusion: The new procedure of EUCAST for antifungal susceptibility testing is a reproducible method within and between laboratories and offers several advantages over the NCCLS approved method.
Similar articles
- Multicentre determination of quality control strains and quality control ranges for antifungal susceptibility testing of yeasts and filamentous fungi using the methods of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST).
Cuenca-Estrella M, Arendrup MC, Chryssanthou E, Dannaoui E, Lass-Florl C, Sandven P, Velegraki A, Rodriguez-Tudela JL; AFST Subcommittee of EUCAST. Cuenca-Estrella M, et al. Clin Microbiol Infect. 2007 Oct;13(10):1018-22. doi: 10.1111/j.1469-0691.2007.01790.x. Epub 2007 Aug 13. Clin Microbiol Infect. 2007. PMID: 17697001 - Antifungal susceptibility of bloodstream yeasts isolated at a public children's hospital in Brazil: comparison of the Etest and the AFST-EUCAST microdilution method.
Matsumoto FE, Dias AL, Melhem MS, Szeszs MW, Auler ME, Ruiz LS, Gonçalves da Silva E, Gandra RF, Paula CR. Matsumoto FE, et al. Can J Microbiol. 2007 Dec;53(12):1300-6. doi: 10.1139/W07-095. Can J Microbiol. 2007. PMID: 18059562 - Multisite reproducibility of the Etest MIC method for antifungal susceptibility testing of yeast isolates.
Pfaller MA, Messer SA, Bolmström A, Odds FC, Rex JH. Pfaller MA, et al. J Clin Microbiol. 1996 Jul;34(7):1691-3. doi: 10.1128/JCM.34.7.1691-1693.1996. J Clin Microbiol. 1996. PMID: 8784571 Free PMC article. - Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC. Arendrup MC. Dan Med J. 2013 Nov;60(11):B4698. Dan Med J. 2013. PMID: 24192246 Review. - Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Laboratory Standards.
Rex JH, Pfaller MA, Galgiani JN, Bartlett MS, Espinel-Ingroff A, Ghannoum MA, Lancaster M, Odds FC, Rinaldi MG, Walsh TJ, Barry AL. Rex JH, et al. Clin Infect Dis. 1997 Feb;24(2):235-47. doi: 10.1093/clinids/24.2.235. Clin Infect Dis. 1997. PMID: 9114154 Review.
Cited by
- Clinical case of endocarditis due to Trichosporon inkin and antifungal susceptibility profile of the organism.
Ramos JM, Cuenca-Estrella M, Gutierrez F, Elia M, Rodriguez-Tudela JL. Ramos JM, et al. J Clin Microbiol. 2004 May;42(5):2341-4. doi: 10.1128/JCM.42.5.2341-2344.2004. J Clin Microbiol. 2004. PMID: 15131229 Free PMC article. - Antifungal effects on metabolite profiles of medically important yeast species measured by nuclear magnetic resonance spectroscopy.
Coen M, Bodkin J, Power D, Bubb WA, Himmelreich U, Kuchel PW, Sorrell TC. Coen M, et al. Antimicrob Agents Chemother. 2006 Dec;50(12):4018-26. doi: 10.1128/AAC.00439-06. Epub 2006 Sep 18. Antimicrob Agents Chemother. 2006. PMID: 16982786 Free PMC article. - Candida palmioleophila: characterization of a previously overlooked pathogen and its unique susceptibility profile in comparison with five related species.
Jensen RH, Arendrup MC. Jensen RH, et al. J Clin Microbiol. 2011 Feb;49(2):549-56. doi: 10.1128/JCM.02071-10. Epub 2010 Dec 8. J Clin Microbiol. 2011. PMID: 21147953 Free PMC article. - Fungicidal Activity of Silver and Silica Nanoparticles against Aspergillus sydowii Isolated from the Soil in Western Saudi Arabia.
Alhazmi NM. Alhazmi NM. Microorganisms. 2022 Dec 29;11(1):86. doi: 10.3390/microorganisms11010086. Microorganisms. 2022. PMID: 36677378 Free PMC article. - Correlation of the MIC and dose/MIC ratio of fluconazole to the therapeutic response of patients with mucosal candidiasis and candidemia.
Rodríguez-Tudela JL, Almirante B, Rodríguez-Pardo D, Laguna F, Donnelly JP, Mouton JW, Pahissa A, Cuenca-Estrella M. Rodríguez-Tudela JL, et al. Antimicrob Agents Chemother. 2007 Oct;51(10):3599-604. doi: 10.1128/AAC.00296-07. Epub 2007 Jul 23. Antimicrob Agents Chemother. 2007. PMID: 17646421 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources